Live Breaking News & Updates on Covovax

Stay informed with the latest breaking news from Covovax on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Covovax and stay connected to the pulse of your community

National News: SII's Covovax for those aged 12+ gets panel nod | India News – Rashtra News

SII’s Covovax for those aged 12+ gets panel nod | India News - Rashtra News : Rashtra News #SIIs #Covovax #aged #panel #nod #India #News #Times #India The Covid-19 working group under the government’s vaccine advisory body has recommended use of the Serum Institute of India’s Covovax in the national vaccination programme for those aged

India , National-technical-advisory-group-on-immunisation , Serum-institute-of-india-covovax , India-news , Rashtra-news , Serum-institute , National-technical-advisory-group , Sports-news , Latest-business-news , Latest-world , News-source

Current COVID strain mild, SII has produced five to six million Covovax doses, says SII CEO Adar Poonawalla

India has recorded 12,193 fresh COVID-19 cases in a span of 24 hours, with the number of active cases of the infection going up to 67,556, the Union health ministry said on Saturday.

India , Tamil-nadu , Uttar-pradesh , Serum-institute-of-india , Centre-on , Serum-institute , Adar-poonawalla , Coronavirus , Sii , Covid-19 , Covovax

Covovax booster dose to be available on CoWIN soon, will be priced at Rs 225 per dose plus GST

Covovax can be administered to people who have already been administered Covaxin or Covishield. As of last month, the Covid-19 Working Group headed by Dr NK Arora recommended the same to the Health Ministry., Health News, Times Now

India , New-delhi , Delhi , Prakash-kumar-singh , Serum-institute-of-india , European-medicines-agency , Novavax-inc , World-health-organisation , Health-ministry , World-health-organization-on , Union-health-ministry , Serum-institute

Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults

The DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9, 2022, and in the 7-11 age group on June 28, 2022, subject to certain conditions.

India , Prakash-kumar-singh , Drug-administration , Serum-institute-of-india , European-medicines-agency , World-health-organisation , Novavax-inc , Serum-institute , Drugs-controller-general , Covovax , Ovovax-vaccine , Ovid-vaccine

As Covid cases rise, Serum Institute wants Covovax to be added as booster vaccine on CoWIN app

Whether a person has taken two doses of Serum's Covishield or Bharat Biotech's Covaxin, Covovax will act as a third dose for both.

India , World-health-organisation , Drug-administration , Serum-institute , Bharat-biotech , Covid , Serum , Covovax , Booster , Vaccine , Cowin

DCGI Approves Market Authorisation for SII's COVID-19 Vaccine 'Covovax' As Heterologous Booster Dose

The Drug Controller General of India (DCGI ) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said on Monday. DCGI Approves Market Authorisation for SII’s COVID-19 Vaccine ‘Covovax’ As Heterologous Booster Dose.

India , New-delhi , Delhi , Prakash-kumar-singh , Age-group , Regulatory-affairs , European-medicines-agency , World-health-organization , Serum-institute-of-india , Expert-committee , Novavax-inc , Drug-controller-general